Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $331.50 USD
Change Today +3.61 / 1.10%
Volume 2.2K
As of 11:04 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

atrion corporation (ATRI) Snapshot

Open
$340.00
Previous Close
$327.89
Day High
$340.00
Day Low
$330.94
52 Week High
12/18/14 - $355.91
52 Week Low
07/28/14 - $278.01
Market Cap
617.5M
Average Volume 10 Days
21.3K
EPS TTM
$14.08
Shares Outstanding
1.9M
EX-Date
03/13/15
P/E TM
23.5x
Dividend
$3.00
Dividend Yield
0.87%
Current Stock Chart for ATRION CORPORATION (ATRI)

Related News

No related news articles were found.

atrion corporation (ATRI) Related Businessweek News

No Related Businessweek News Found

atrion corporation (ATRI) Details

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products for medical applications primarily in the United States, Canada, and internationally. The company’s fluid delivery products comprise luer syringe check valves and one-way valves; tubing clamps; and specialized intravenous sets that are used in anesthesia and oncology applications. Its cardiovascular products include MPS2 Myocardial Protection System that delivers essential fluids and medications to the heart during open-heart surgery; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in invasive surgical procedures; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The company’s ophthalmic products comprise contact lens disinfection cases; and a line of balloon catheters that are used for the treatment of nasolacrimal duct obstruction in children and adults. It also manufactures instrumentation and associated disposables, which measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, the company produces inflation systems and valves, which are used in marine and aviation safety products; and one-way and two-way pressure relief valves for use on electronics cases, munitions cases, pressure vessels, transportation container cases, escape slides, and other medical and non-medical applications. Atrion Corporation sells its products to physicians, hospitals, clinics, and other treatment centers, as well as other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. The company was founded in 1944 and is based in Allen, Texas.

483 Employees
Last Reported Date: 03/13/15
Founded in 1944

atrion corporation (ATRI) Top Compensated Officers

Chief Executive Officer, President and Presid...
Total Annual Compensation: $600.0K
Executive Chairman, Member of Executive Commi...
Total Annual Compensation: $600.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $270.0K
Compensation as of Fiscal Year 2014.

atrion corporation (ATRI) Key Developments

Atrion Corp. Declares Unchanged Quarterly Dividend, Payable on March 31

Atrion Corp. announced that it will distribute an unchanged quarterly dividend of $0.75 per share on March 31 to holders of record on March 17, with an ex-dividend date of March 13. The dividend carries an annual yield of 0.9%.

ATRION Corp. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

ATRION Corp. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported revenues of $32,693,000 compared to $31,851,000 for the same period a year ago. Operating income was $8,632,000 compared to $8,336,000 for the same period a year ago. Income before income taxes was $8,920,000 compared to $8,651,000 for the same period a year ago. Net income was $6,040,000 or $3.11 per share compared to $5,768,000 or $2.88 per share for the same period a year ago. Income per diluted share was $3.08 compared to $2.87 a year ago. For the year, the company reported revenues of $140,762,000 compared to $131,993,000 for the same period a year ago. Operating income was $40,817,000 compared to $37,944,000 for the same period a year ago. Income before income taxes was $42,021,000 compared to $39,265,000 for the same period a year ago. Net income was $27,808,000 or $14.20 per share compared to $26,582,000 or $13.22 per share for the same period a year ago. Income per diluted share was $14.08 compared to $13.18 a year ago.

Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2014

The Board of Directors of Atrion Corporation announced its quarterly dividend of 75 cents per share on its outstanding shares of common stock. This dividend will be payable on December 15, 2014 to stockholders of record at the close of business on December 1, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRI:US $331.50 USD +3.61

ATRI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ATRI.
View Industry Companies
 

Industry Analysis

ATRI

Industry Average

Valuation ATRI Industry Range
Price/Earnings 23.3x
Price/Sales 4.5x
Price/Book 4.2x
Price/Cash Flow 22.0x
TEV/Sales 4.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATRION CORPORATION, please visit www.atrioncorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.